Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
720 Results Found
CDC: Masks are now optional for 90% of the country
The Centers for Disease Control and Prevention yesterday said more than 90% of the U.S. population now lives in a county with a low or medium COVID-19 Community Level, a new CDC measure for communities considering whether to require face coverings in public indoor settings.
COVID-19 Vaccines Resources
Important updates for health care supply chain on the progress and distribution of COVID-19 vaccines.
CDC Relaxes Masking Guidance; Mask Requirement Remains in Place for Hospitals, Other Health Care Settings
The Centers for Disease Control and Prevention today announced a major adjustment of its federal masking guidance pertaining to the COVID-19 public health emergency, including changes to the metrics that communities are urged to use when determining whether to require face coverings in indoor settings.
FDA authorizes dosing change for monoclonal antibody treatment
The Food and Drug Administration authorized a revised dosing regimen for the combination monoclonal antibody therapy Evusheld when used to prevent COVID-19 in certain patients, citing data showing a higher initial dose may better prevent infection by certain omicron subvariants.
CDC updates vaccine dose timing recommendation; Sanofi and GSK to seek FDA authorization for COVID-19 vaccine
The Centers for Disease Control and Prevention said some people may wish to receive their second dose of the Pfizer or Moderna COVID-19 vaccine up to eight weeks after the first, especially males aged 12 to 39.
Medicare releases billing code for new COVID-19 omicron variant treatment
The Centers for Medicare & Medicaid Services has released Medicare payment codes effective Feb. 11 for administering the monoclonal antibody bebtelovimab, effective against the omicron COVID-19 variant.
FDA alerts providers to COVID-19 rapid test recall
The Food and Drug Administration announced a Class 1 recall of the E25Bio COVID-19 Direct Antigen Response Test, which was marketed and distributed to U.S. customers without authorization or approval.
CMS, CDC respond to rise in HAIs during pandemic
Federal officials at the Centers for Medicare and Medicaid Services and the Centers for Disease Control and Prevention called for a renewed focus on patient safety
Vaccination during pregnancy protects infants from COVID-19
Completion of a 2-dose mRNA COVID-19 vaccination series during pregnancy might help prevent COVID-19 hospitalization among infants
CDC study: Maternal COVID-19 vaccination helps protect infants
Receiving two doses of the Pfizer or Moderna COVID-19 vaccine during pregnancy might help prevent your infant from being hospitalized for COVID-19 in the first six months after birth, according a study released today by the Centers for Disease Control and Prevention.